Initial Progression-Free Survival after Non-First Line TKIs Therapy Potentially Guides Immediate Treatment after Its Failure in Advanced Non-Small Cell Lung Cancer

OBJECTIVE: The standard therapy after failure of the initial non-first line epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) treatment in advanced non-small cell lung cancer (NSCLC) has not yet been established. The aim of the current study was to identify whether the 2(nd) TKI...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Fang, Guo, Gui-fang, Qiu, Hui-juan, He, Wen-zhuo, Zhou, Fei-fei, Chen, Xu-xian, Hu, Pi-li, Zhang, Bei, Yin, Chen-xi, Zhang, Li, Xia, Liang-ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chinese Anti-Cancer Association 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3643642/
https://www.ncbi.nlm.nih.gov/pubmed/23691453
http://dx.doi.org/10.3969/j.issn.2095-3941.2012.01.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3643642/
https://www.ncbi.nlm.nih.gov/pubmed/23691453
http://dx.doi.org/10.3969/j.issn.2095-3941.2012.01.007

Ejemplares similares